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Summary
Objective:  The  purpose  of  this  article  is  to  illustrate  the  use  of  radiofrequency  and  laser
ablation in  head  and  neck  oncology  and  to  describe  the  management  of  a  case  of  laryngeal
chondrosarcoma  in  a  90-year-old  patient.
Case report:  A  90-year-old  man,  WHO  performance  status  3,  with  low-grade  laryngeal  chon-
drosarcoma  was  seen  in  the  outpatients  department  at  the  end  of  2008  for  assessment
of dysphonia.  Total  laryngectomy  was  considered  to  be  too  invasive  and  was  consequently
excluded.  The  patient  was  initially  tracheotomized  under  local  anaesthesia  to  relieve  dysp-
noea and  was  subsequently  managed  symptomatically  by  radiofrequency  and  laser  ablation
to ensure  laryngeal  disobstruction,  allowing  the  patient  to  be  extubated  followed  by  speech
therapy and  oral  feeding  rehabilitation.
Discussion/conclusion:  This  patient  received  symptomatic  palliative  treatment  with  a  combi-
nation of  radiofrequency  and  laser.  Radiofrequency  ablation  can  be  applied  in  head  and  neck
oncology as  an  alternative  treatment  to  surgery  allowing  improvement  of  quality  of  life  and
survival.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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lIntroduction
Radiofrequency  ablation  is  currently  used  for  the  manage-
ment  of  renal  tumours,  and  liver,  bone  and  lung  metastases.
Several  studies  have  also  demonstrated  the  value  of
radiofrequency  ablation  in  the  treatment  of  upper  airway
tumours.  However,  no  study  has  reported  the  results  of  a
combination  of  laser  and  radiofrequency  ablation.  In  the
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doi:10.1016/j.anorl.2012.02.009ight  of  a  case  report,  this  article  illustrates  application  of
adiofrequency  combined  with  laser  to  improve  quality  of
ife  in  the  management  of  laryngeal  chondrosarcoma.
ase report
 90-year-old  man  with  WHO  performance  status  3  was
eferred  by  his  general  practitioner  at  the  end  of  2008  with
hronic  dysphonia  progressively  deteriorating  over  a  period
f  5 months.  This  patient,  a  former  smoker  with  cessation
or  more  than  15  years,  had  a  history  of  treated  prostatic
served.
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Figure  1  Axial  CT  scan  of  the  neck  centered  on  the  glottis,  performed  (from  left  to  right):  at  the  initial  stage  with  a  lesion
centered on  the  cricoid  cartilage  with  an  eroded  appearance;  after  treatment:  clear  airway  after  endolaryngeal  tumour  resection;
a atm
c
a
y
s
t
r
m
r
t
w
g
d
p
c
m
m
t
l
w
i
a
e
a
v
a
m
t
6
5
s
R
T
p
s
o
v
l
s
b
t
t
o
v
a
m
D
T
s
i
[
T
e
t
r
p
m
f
q
s
a
c
t
c
a
ct the  time  of  relapse  in  2011  before  a  second  endoscopic  tre
artilage, narrowing  the  laryngeal  lumen.
denocarcinoma  and  non-Hodgkin’s  lymphoma  treated  10
ears  previously  and  tight  aortic  stenosis.
Clinical  examination  by  nasal  endoscopy  revealed  a  lesion
urrounding  the  base  of  the  epiglottis.  The  whitish  and
ranslucent  lesion  was  smooth  and  clearly  demarcated  with
egular  contours,  covered  by  a  ﬁne  vascular  network  with  a
obile  larynx  and  no  signs  of  subglottal  extension.  CT  scan
evealed  a  low-density  lesion,  centered  on  the  thyroid  car-
ilage  that  appeared  to  be  eroded,  classiﬁed  as  a  T4  lesion
ith  1  cm  lymph  nodes  (Fig.  1).  Biopsy  demonstrated  low-
rade  laryngeal  chondrosarcoma.  PET-CT  did  not  reveal  any
istant  metastases.
A geriatric  consultation,  requested  in  view  of  this
atient’s  serious  comorbidities,  especially  cardiological,
oncluded  on  the  need  for  cardiovascular  and  nutritional
anagement  prior  to  treatment.  This  case  was  discussed  in
ultidisciplinary  ward  rounds  and  it  was  initially  decided
o  perform  total  laryngectomy,  the  standard  treatment  for
aryngeal  chondrosarcoma  [1].  However,  as  this  operation
as  contraindicated  in  view  of  the  patient’s  general  status,
t  was  decided  to  propose  watchful  waiting  and  surveillance
ccording  to  the  patient’s  respiratory  symptoms.
Five  months  later,  in  the  presence  of  progressively  wors-
ning  dyspnoea,  tracheotomy  was  performed  under  local
naesthesia,  allowing  management  of  the  patient’s  cardio-
ascular  disease  (valvuloplasty),  thereby  eliminating  the
naesthetic  contraindication  and  allowing  surgical  manage-
ent  of  the  laryngeal  tumour.
The  patient  was  treated  by  two  laser  photovaporiza-
ion  and  radiofrequency  ablation  sessions  at  an  interval  of
 months  (a  ﬁrst  10-minute  session  at  80  W  and  a  second
-minute  session  at  90  W  followed  by  a  10  W  continuous
uperpulse  laser  session).
esultshe  patient  was  considerably  improved  postoperatively  with
ersistence  of  dysphonia  and  extubation  was  possible  the
ame  year.  In  May  2011,  the  patient  presented  recurrence
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eent.  Poorly  demarcated  tumour  mass  arising  from  the  cricoid
f  dysphonia  with  the  tumour  bulging  into  the  laryngeal
estibule  (Fig.  1).  Endoscopic  partial  laryngectomy  of  the
aryngeal  vestibule  was  proposed,  according  to  the  same
equence  as  before.  The  postoperative  course  was  marked
y  repeated  episodes  of  aspiration,  improved  by  speech
herapy  (acquisition  of  a  fundamental  laryngeal  conversa-
ional  voice,  effective  cough  with  progressive  introduction
f  oral  feeding).  At  last  follow-up,  3  years  after  the  initial
isit,  the  patient  presented  no  signs  of  tumour  progression
nd  no  clinically  visible  lesion,  with  surveillance  every  3
onths.
iscussion
he  standard  treatment  for  laryngeal  chondrosarcoma  is
urgery.  Endoscopic  resection  is  not  recommended,  as  it
s  associated  with  a  high  recurrence  rate  (close  to  70%)
1].  Surgical  treatment  depends  on  tumour  extension.
otal  laryngectomy  should  be  proposed  for  a  cricoid  lesion
xtending  beyond  the  midline.  Chondrosarcomas  are  refrac-
ory  to  adjuvant  chemotherapy  and  radiotherapy.  However,
adiotherapy  can  be  considered  as  palliative  treatment  in
atients  with  inoperable  tumours  [2,3].
Radiofrequency  ablation,  frequently  used  for  the  treat-
ent  of  renal  tumours  or  liver  metastases,  is  also  indicated
or  the  treatment  of  upper  airway  tumours  [4—6]. Radiofre-
uency  ablation  can  also  be  proposed  in  the  palliative
etting  when  no  other  treatment  options  are  available  [7]
nd,  according  to  recent  studies,  can  be  combined  with
hemotherapy  or  radiotherapy  [8,9].
Radiofrequency  ablation  ensures  destruction  of  the
umour  with  no  iatrogenic  risks  by  creating  a  zone  of  thermo-
oagulation,  resulting  in  a  zone  of  necrosis.  Radiofrequency
blation  consists  of  application  of  an  electrode  delivering  a
urrent  that  heats  the  tumour  to  a temperature  of  at  least
5 ◦C,  a  temperature  considered  to  be  lethal  for  cells.  This
emperature  must  be  reached  in  the  entire  tumour  volume
nd,  when  possible,  slightly  beyond  this  volume  in  order  to
nsure  clear  margins.  Several  electrodes  can  be  inserted  to
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RFigure  2  Laryngeal  endoscopic  view  of  the  radiofrequency
electrode  in  the  tumour.
increase  the  diameter  of  the  treated  zone  by  promoting  dif-
fusion  of  the  current  away  from  the  needle.  Limitations  to
radiofrequency  ablation  are  the  size  of  the  tumour,  which
must  not  exceed  14  mm  in  diameter,  and  the  presence  of
multiple  lesions  [10].
In  the  case  reported  here,  radiofrequency  ablation  was
performed  under  general  anaesthesia  by  microsuspension
direct  laryngoscopy.  A  RITA  electrode  connected  to  a  genera-
tor  was  placed  on  the  superior  and  inferior  poles  of  the  lesion
(Fig.  2).  The  electrode  was  then  placed  percutaneously  for
ablation  of  the  prelaryngeal  tumour,  allowing  internal  and
external  treatment  of  the  tumour.
Radiofrequency  was  followed  by  laser  photovaporization
to  cauterize  the  zone  destroyed  by  radiofrequency.
ConclusionTwo  particular  aspects  of  this  case  report  should  be  stressed.
Firstly,  curative  treatment  was  not  feasible  in  this  elderly
patient,  but  Laser  and  radiofrequency  ablation,  in  collabora-
tion  with  geriatric  oncology  assessment  and  speech  therapy,
[93
mproved  the  patient’s  survival  and  quality  of  life.  Secondly,
nvasive  surgery  was  contraindicated  in  this  patient  in  view
f  his  history,  but  an  alternative  treatment  option  was  pro-
osed,  allowing  complete  clinical  cure.
Based  on  our  experience  of  radiofrequency  ablation,  this
echnique  can  be  applied  to  other  tumour  sites  not  acces-
ible  to  surgical  resection,  such  as  synovial  sarcoma  of  the
ace  and  ethmoid  adenocarcinoma  in  combination  with  neu-
onavigation,  demonstrating  that  radiofrequency  can  be  an
lternative  treatment  to  improve  survival  and  quality  of  life.
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